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The vasopressin-oxytocin family of peptides is of 
very ancient lineage, found in organisms as diverse as 
hydra and man. Although these peptides have been 
intensively studied in vertebrates, the presumably 
more extensive invertebrate series was defined pri-
marily by immunological methods. In this report, we 
describe the purification and structures of two peptides 
of the vasopressin-oxytocin family from molluscs 
("Conopressins"), which were found in the venom of 
fish-hunting marine snails of the genus Conus. The 
biological activity observed when the two snail pep-
tides are injected intracerebrally into mice is very 
similar to that elicited by the vertebrate neurohypo-
physeal hormones and presumably reflects their ac-
tions upon a common receptor in the brain. The se-
quences of the purified peptides reveal unique features 
not found in the vertebrate peptide series, most notably 
an additional positive charge. These are the first mem-
bers of the invertebrate series of the vasopressin-oxy-
tocin family to be characterized biochemically. 
The sequences of these peptides are: from Conus 
geographus venom, Lys-conopressin-G, Cys-Phe-Ile-
Arg-Asn-Cys-Pro-Lys-Gly-NH2 ; and from Conus stria-
tus venom, Arg-conopressin-S, Cys-Ile-Ile-Arg-Asn-
Cys-Pro-Arg-Gly-NH2 • 
The vasopressin-oxytocin peptides were first characterized 
as neurohypophyseal hormones in mammals. Their biological 
activity was defined 30 years before (1) and their structures 
were elucidated in the 1950s by Du Vigneaud and his co-
workers (2). In recent years, the proposed physiological role 
and phylogenetic distribution of this family of peptides has 
been greatly expanded. These peptides are released in tissues 
other than the pituitary in mammals, and vasopressin appears 
to play a role as a neurotransmitter or cotransmitter in 
mammalian brain. In addition, compelling evidence has ac-
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cumulated for the presence of these peptides in a number of 
invertebrate systems, including insects (3-5) and molluscs (6, 
7). This evidence is primarily immunological, most often 
immunocytochemical, staining with antipeptide antibodies. 
Recently Grimmelikhuijzen et al. (8) reported oxytocin/ 
vasopressin-like immunoreactivity in Hydra. This coelenter-
ate has one of the simplest nervous systems known: although 
synapses and secretory vesicles are present, small molecule 
neurotransmitters such as acetylcholine and catecholamines 
appear to be absent (9, 10). The high concentration of pep tides 
in the neurons of Hydra has led to the intriguing suggestion 
that in primordial nervous systems the first neurotransmitters 
may have been exclusively peptides (10). Thus, included in 
the set of putative Hydra neurotransmitters is a peptide of 
the vasopressin-oxytocin family (8). 
These results suggest that these peptides have an evolu-
tionary lineage that dates back _109 years. To date, only the 
vertebrate members of this peptide family have been purified 
and fully characterized, leaving the relationship between them 
and the ancient line of invertebrate peptides undefined. In 
this report we describe the first purification and sequence 
analysis of invertebrate vasopressin-oxytocin peptides. These 
peptides have been purified from an unexpected source, the 
venom of the fish-hunting cone snails (Conus). We propose 
the generic term conopressin for all vasopressin-oxytocin 
homo logs found in Conus. The Conus venoms have proven to 
be rich sources of biologically active peptides (11). Peptide 
toxins which inhibit calcium channels (12, 13), sodium chan-
nels (14, 15), and the acetylcholine receptor (16, 17), as well 
as a peptide which induces a sleep-like state in mice (18, 19), 
have already been described. 
MATERIALS AND METHODS 
Venoms-Conus geographus and Conus striatus were collected 
around the island of Marinduque, Philippines. Venom ducts were 
dissected from freshly killed snails, and the crude venom was sub-
jected to preliminary purification as described previously (12). 
Isolation and Bioassay of Peptides-Crude venom extract from C. 
geographus was fractionated on a Sephadex G -25 column as previously 
described (12) and the "scratcher peptide" was subsequently purified 
from the third major protein peak which was designated as Peak C 
by Olivera et al. (12). Reverse-phase HPLC' was used to separate 
different peptide fractions with the appropriate biological activity as 
shown in Fig. I, and the peptides were assayed by intracerebral 
injection into mice as previously described (12). The scratcher peptide 
of C. striatus venom was purified essentially in the same manner. 
Amino Acid Analysis-Peptide samples were hydrolyzed in vacuo 
in 6 N HCl, 1 % phenol for 18 h at 105 ·C. For C. striatus, amino acid 
analysis was done by reverse-phase HPLC of phenyl-thiocarbamyl 
derivatives (20). 
Peptide Sequencing-Reduction and carboxymethylation was car· 
ried out as previously described (16) except that a volatile buffer (0.02 
M N-ethylmorpholine) was used. Sequencing of reduced and carbox-
ymethylated peptides was carried out by sequential Edman degrada-
tion in a Beckman 8900 spinning cup sequenator, using 0.1 M Quadrol 
buffer and Polybrene carrier (21). Phenylthiohydantoin-derivatives 
were identified by HPLC on a Hewlett-Packard 1084B instrument 
using an Ultrasphere ODS column (0.46 X 15 em, 5-1' particle size, 
endcapped) eluted with a gradient of acetonitrile in 0.05 M sodium 
acetate, pH 4.5 (16). 
, The abbreviation used is: HPLC, high performance liquid chro-
matography. 
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FIG. 1. Purification of the scratcher peptide from Conus 
geographus venom. One gram of crude lyophilized venom was 
extracted and fractionated on a Sephadex G-25 column as previously 
described (12). The first 6 of 21 successive fractions containing 
"shaker activity" (now known as the calcium channel blockers, w-
conotoxins) were pooled and chromatographed on a Vydac C,s semi-
preparative column eluted with a gradient of acetonitrile in 0.1 % 
trifluoroacetic acid (A). The peak indicated by an arrow elicited both 
shaking and scratching activities. Chromatography of material from 
this peak on a Vydac C,s analytical column eluted with a gradient of 
acetonitrile in 0.05% heptafluorobutyric acid (B) separated the 
"scratcher" from the "shaker" activity. The scratcher peak, when 
rechromatographed under the same conditions as in B, appears ho-
mogeneous (C). The absorbance plotted is at 214 nm. Dashed lines 
indicate the gradient of acetonitrile. 
RESULTS 
Assay and Purification of Conopressins-Intracerebral in-
jection of these peptides at levels of >0.5 nmol causes mice to 
scratch themselves within a few minutes. The "scratcher" 
activity is masked in crude venom by the actions of other 
toxins, particularly the lethal ones. The first conopressin was 
detected in Conus venom fractions from Sephadex G-25 fil-
tration, where its elution profile overlapped extensively with 
that of the Ca2+ channel toxins (w-conotoxins). On reverse-
phase HPLC in 0.1% trifluoroacetic acid/acetonitrile (Fig. 
!A), the C. geographus activity was associated with the leading 
edge of the major peak of w-conotoxin GVIA or the "shaker 
peptide". On rerunning in 0.05% heptafluorobutyric acid/ 
acetonitrile (Fig. 1B) a clean separation was obtained, the 
scratching effects being elicited only by material from a minor 
peak. This material, which was apparently homogeneous, was 
then analyzed by sequencing. Purification of conopressin from 
C. striatus venom followed essentially the same steps. 
Peptide Structural Analysis-The peptides were reduced 
and carboxymethylated as described under "Materials and 
Methods" (16) and then applied to the sequenator cup. In 
both cases the sequences were unambiguous, although there 
were heavy losses of the COOH-terminal Gly, a common 
experience with amidated peptides. Results of the analysis for 
both conopressins are given in Table I, and sequences of the 
two conopressins are shown in Table II. 
Amino acid analysis of conopressin S was in agreement 
with the sequence, though the lIe· lIe dipeptide was only 
hydrolyzed to approximately 50%. Analysis was not carried 
out for conopressin G. The proposed structures, including the 
COOH-terminal amides, were also confirmed by fast atom 
bombardment mass spectrometry, with protonated molecular 
ions (MH+) of 1034 and 1028 for conopressins G and S, 
respectively. The sequence assignments have been confirmed 
by peptide synthesis; details of the synthesis, comparisons of 
natural versus synthetic material, and a more detailed phys-
iological characterization of these peptides will be described 
elsewhere.2 
2 W. R. Gray, R. Zeikus, and C. A. Ramilo, manuscript in prepa-
ration. 
TABLE I 
Sequence analysis of conopressins 
PTH, phenylthiohydantoin-derivative. 
Conopressin G Conopressin S 
Step Assigned Step Assigned 
residue Yield residue Yield 
nmolofPTH nmolof PTH 
1 Cys 1.15 1 Cys 1.67 
2 Phe 2.11 2 lie 2.30 
3 lie 2.06 3 lie 2.36 
4 Arg 1.55 4 Arg 0.75 
5 Asn 0.57 5 Asn 1.05 
6 Cys 0.60 6 Cys 1.02 
7 Pro 0.84 7 Pro 0.59 
8 Lys 0.65 8 Arg 0.29 
9 Gly 0.04 9 Gly 0.05 
The structural similarity with vasopressin and other neu-
rohypophyseal hormones is obvious from Table II. Thus, the 
peptide from C. geographus is designated Lys-conopressin-G 
and the peptide from C. striatus is designated Arg-conopres-
sin-So This nomenclature follows both the commonly used 
system for vasopressins, as well as for Conus peptides (22). 
Biological Effects of Intracerebral Injection-The biological 
responses elicited by intracerebral injection of conopressin G 
were compared with those elicited by Arg-vasopressin and 
oxytocin (Table III). They were similar in all cases, with 
conopressin being intermediate in potency between the ver-
tebrate hormones. The scratching response is dose-dependent 
with respect to time of onset and duration of symptoms. At 
very low doses, the mice have the appearance of grooming 
their faces. The symptomatology elicited by these peptides 
upon intracerebral injection into mice is highly characteristic 
(23-25), presumably diagnostic of a specific central nervous 
system receptor. This may be homologous to the receptor 
which controls the stereotypic "flanking marking" response 
characterized in Golden hamsters (26); scratching is one fea-
ture of this territorial behavior. 
DISCUSSION 
The peptides isolated from C. geographus and C. striatus 
are clearly members of the vasopressin-oxytocin family (Ta-
bles II and 111), yet they have distinctive features. A basic 
residue, Lys or Arg, at position 8 is strongly correlated with 
pressor activity in vertebrate hormones and in hundreds of 
synthetic analogues (27). Since both of the Conus peptides 
share this feature, we propose the name "conopressin" for the 
group. The presence of lIe at position 3 could be used to argue 
in favor of "conotocin," but this is confusingly similar to the 
well-established "conotoxin". Both peptides have neutral hy-
drophobic residues at position 2, Phe in conopressin G and 
lIe in conopressin S. All the vertebrate peptides have Tyr at 
this position, with the sole exception of phenypressin from 
marsupials (see Table II). An aromatic residue at position 2 
is believed to be specifically required for interaction with 
neurophysin in vertebrate systems (28). The presence of lIe 
in conopressin S implies either that there are no endogenous 
neurophysins for conopressin(s) or that Conus neurophysins 
are more tolerant of substitutions at position 2. 
The unique feature shared by both snail peptides is the 
presence of a basic residue, Arg, at position 4. This gives them 
a net charge of +3, higher than that of the vasopressins (+2) 
or oxytocins (+ 1). Whether this contributes unique biological 
properties will be of great interest. An arginine vasopressin 
analogue with this substitution has been synthesized (29) and 
shown to be similar to vasopressin in its antidiuretic and 
pressor activities. 
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Amino acid sequences of the scratcher peptide and some vertebrate neurohypophyseal hormones 
Peptide Amino acid sequence Charge Animal group 









B. Vertebrate neurohypophyseal hormones· 
Lys-vasopressin Cys-Tyr-Phe-Gln -Asn -Cys-Pro-Lys-Gly-(NH.) +2 Suiformes, peccaries, 




















Ancestral vertebrate peptide 
Cys-Tyr-lie-Gin -Asn -Cys-Pro-Leu -G ly- (NH2 ) 





Cartilaginous fishes (ray) 
a We propose to call all peptides of this homologous peptide set "conopressins." The nomenclature is adapted 
from that used for conotoxins, i.e. G (for C. geographus), S (for C. striatus) (22). Thus, the first conopressin from 
Conus magus (if different in sequence) would be conopressin M. 
























a Different levels of each peptide starting at 5 nmol and using 
successive 2- to 5-fold dilution intervals were injected into a series of 
mice. Eleven mice were used for the Lys-conopressin-G series and 6 
mice each for Arg-vasopressin and oxytocin. The lowest concentration 
of each peptide at which definite grooming behavior was observed is 
indicated. The experiments with conopressin were performed with 
two different batches of toxin. 
Peptides of the vasopressin-oxytocin family are probably 
present in all nervous systems, including the highly primitive 
ones such as that of Hydra which lack the "classical" neuro-
transmitters. Their function in Conus is unknown, especially 
in the venom. In Aplysia califarnica Lukowiak et al. (30) 
demonstrated that arginine vasopressin enhances suppressive 
control over gill reflex behavior when it is applied to the 
abdominal ganglion at 10-12 M concentrations. They subse-
quently showed that the anterior ganglia of Aplysia contain 
an arginine vasotocin-like peptide, as judged by its immuno-
logical reactivity and HPLC behavior (7)_ In our HPLC 
systems the conopressins are resolved from arginine vasoto-
cin. 
It is noteworthy, given the conserved homology of the 
vertebrate vasopressin-oxytocin family, that the conopressins 
sequenced from two snails in the same genus differ in two out 
of nine residues. In contrast, arginine vasotocin from teleosts 
to birds exhibits no sequence changes at all (see Table II) , 
and changes among other members are minor. Despite the 
lack of stringent sequence conservation in conopressins, the 
fact that the positive charge in position 4 is found in both C. 
geographus and C. striatus venoms suggest either that this 
structural feature is selected for and/or that both peptides 
evolved from an endogenous molluscan peptide with a positive 
charge at position 4. We expect that the occurrence of cono-
pressins in Conus venoms is more likely due to evolution from 
pre-existing snail peptides, rather than to arriving at a func-
tional analog by convergent evolution. Although conopressins 
may be secreted by neuronal tissue innervating the venom 
ducts, it is also possible that conopressins playa role in the 
envenomation process. We suggest that these peptides have 
been used in nervous systems continuously but have been 
used opportunistically for specialized functions, such as neu-
rohypophyseal hormones in mammals (and possibly as venom 
peptides in Conus), and that in different taxa a variety of 
such specialized uses may be found. 
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